Oncocross Revenue

Oncocross had revenue of 29.18M KRW in the quarter ending September 30, 2025, a decrease of -84.03%. This brings the company's revenue in the last twelve months to 884.68M, up 103.05% year-over-year. In the year 2024, Oncocross had annual revenue of 1.07B with 1,071.49% growth.

Revenue (ttm)

884.68M

Revenue Growth

+103.05%

P/S Ratio

173.75

Revenue / Employee

n/a

Employees

n/a

Market Cap

153.71B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.07B	980.68M	1,071.49%
Dec 31, 2023	91.52M	-58.72M	-39.08%
Dec 31, 2022	150.25M	50.25M	50.25%
Dec 31, 2021	100.00M	10.00M	11.11%
Dec 31, 2020	90.00M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5,504.84B
Celltrion	3,895.99B
ALTEOGEN	202.18B
ABL Bio	88.44B
SK Biopharmaceuticals	675.41B
Yuhan	2,136.67B
LigaChem Biosciences	159.27B
Peptron	6.19B

Revenue Rankings